The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of larotrectinib in adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system tumors.
 
Sébastien Perreault
Leadership - Bayer
Stock and Other Ownership Interests - novocure
Honoraria - Bayer
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
Expert Testimony - Bayer
 
Cornelis Martinus van Tilburg
Consulting or Advisory Role - Bayer; Novartis
 
Birgit Geoerger
Consulting or Advisory Role - AZD; Bayer; Boehringer Ingelheim; Novartis; Roche/Genentech
 
Karsten Nysom
Honoraria - Bayer (Inst); Loxo (Inst)
Consulting or Advisory Role - Y-mAbs Therapeutics
Other Relationship - Y-mAbs Therapeutics
 
Ingrid Ora
Consulting or Advisory Role - Bayer
 
Igor T. Gavrilovic
No Relationships to Disclose
 
Ricarda Norenberg
Employment - Bayer
 
Laura Dima
Employment - Bayer
 
Esther A. De La Cuesta
Employment - Bayer
 
Alexander E. Drilon
Honoraria - Foundation Medicine; Medscape; MORE Health; OncLive; Peerview; PeerVoice; Physicans' Education Resource; Research to Practice; Targeted Oncology
Consulting or Advisory Role - 14ner Oncology/Elevation Oncology; Abbvie; Archer; AstraZeneca; Bayer; BeiGene; BerGenBio; Blueprint Medicines; EMD Serono/Merck; Exelixis; Genentech/Roche; Helsinn Therapeutics; Hengrui Therapeutics; Ignyta; Lilly; Loxo; Melendi; Monopteros Therapeutics; Monopteros Therapeutics; MORE Health; Novartis; Pfizer; Remedica; Repare Therapeutics; Takeda/Millennium; TP Therapeutics; Tyra Biosciences; Verastem; Verastem
Research Funding - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - GlaxoSmithKline; Merck; Pfizer; PharmaMar; Puma Biotechnology; Taiho Pharmaceutical; Teva
 
Francois P. Doz
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Loxo (Inst); Roche (Inst); Servier (Inst); SERVIER (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Roche